Full Professor(heuristic)

Genetic Associations and Epidemiology · Genetics

Compare more Genetics professors.

h-index73
i10-index312
Publications739
Citations22,820

Grants

6 total · 6 active

NIH #R01HL180515

Carbonic Anhydrase as a Cardioprotective Target in Anthracycline-induced Cardiotoxicity

Active
Amount
$500K–$600K
Period
2025-09-05 → 2030-05-31
PIs
1

Awarded at MEDICAL COLLEGE OF WISCONSIN

NIH #R01CA289804

The Genetic Epidemiology of Radiation-Associated Contralateral Breast Cancer

Active
Amount
$700K–$800K
Period
2025-05-06 → 2030-04-30
PIs
3

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #R01AI093234

Statistical Methods for Ordinal Variables in HIV/AIDS Studies

Active
Amount
$600K–$700K
Period
2011-05-18 → 2029-11-30
PIs
2

Awarded at VANDERBILT UNIVERSITY MEDICAL CENTER

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

6 total · 6 active

NIH #R01HL180515

Carbonic Anhydrase as a Cardioprotective Target in Anthracycline-induced Cardiotoxicity

Active
Amount
$500K–$600K
Period
2025-09-05 → 2030-05-31
PIs
1

Awarded at MEDICAL COLLEGE OF WISCONSIN

NIH #R01CA289804

The Genetic Epidemiology of Radiation-Associated Contralateral Breast Cancer

Active
Amount
$700K–$800K
Period
2025-05-06 → 2030-04-30
PIs
3

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #R01AI093234

Statistical Methods for Ordinal Variables in HIV/AIDS Studies

Active
Amount
$600K–$700K
Period
2011-05-18 → 2029-11-30
PIs
2

Awarded at VANDERBILT UNIVERSITY MEDICAL CENTER

NSF #2410742

Collaborative Research: Energetic Variation Based Numerical Studies in Complex Fluids with Thermo-Chemo-Mechanical Effects

Active
Amount
$100K–$200K
Period
2024-09-15 → 2027-08-31
PIs
1

Awarded at Illinois Institute of Technology

NIH #R01CA257842

Pre-IND Development of Polymeric Micelles with Dual Drug Payloads for HCC Therapy

Active
Amount
$600K–$700K
Period
2022-08-01 → 2027-06-30
PIs
3

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R01CA258540

Development of irreversible electroporation-based rational combinations to potentiate the activity of cancer immunotherapy against pancreatic ductal adenocarcinoma

Active
Amount
$500K–$600K
Period
2022-02-01 → 2027-01-31
PIs
2

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

Recent Public Signals

  1. New paper: Near-Infrared Light-Driven Microgrooved UCNPs/Azobenzene-LCE Actuators and Substrates for Cardiomyoblast Alignment (ACS Applied Materials & Interfaces)2026-07-04
  2. New preprint: Mechanism of allyl isothiocyanate against Fusarium graminearum2026-01-01
  3. New NIH award: Carbonic Anhydrase as a Cardioprotective Target in Anthracycline-induced Cardiotoxicity2025-09-05

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-08-28

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

ORCID: 0000-0002-8819-2443

Professor Insights

Career Trajectory